(Q69056929)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3595699%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

title

Pharmacokinetics of ketanserin in patients with essential hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3595699%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

main subject

essential hypertension

1 reference

1 reference

1

B Persson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3595699%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

author name string

A Pettersson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3595699%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

T Hedner

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3595699%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

publication date

1 January 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3595699%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

29 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3595699%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3595699%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3595699%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

page(s)

259-265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3595699%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00607573

29 September 2019

exact match

0 references

cites work

Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors

1 reference

12 December 2020

High-performance liquid chromatographic assay with fluorometric detection of ketanserin, a new antihypertensive agent and serotonin S2 antagonist in human plasma, blood and urine

1 reference

12 December 2020

The acute antihypertensive effect of ketanserin increases with age.

1 reference

12 December 2020

Evidence for functional 5-HT2 receptor sites on human blood platelets

1 reference

12 December 2020

Is there alpha-adrenergic blockade and/or serotonergic blockade during chronic ketanserin treatment?

1 reference

12 December 2020

Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration

1 reference

12 December 2020

Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calf

1 reference

12 December 2020

Indirect blood pressure and heart rate measured quickly without observer bias using a semi-automatic machine (auto-manometer)--response to isometric exercise in normal healthy males and its modification by beta-adrenoceptor blockade

1 reference

12 December 2020

The effect of ketanserin on blood pressure and biochemical parameters in treated patients with essential hypertension

1 reference

12 December 2020

Pharmacokinetics of ketanserin in man

1 reference

12 December 2020

Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method

1 reference

12 December 2020

A comparative and long-term evaluation of ketanserin in the treatment of essential hypertension

1 reference

12 December 2020

Antihypertensive mechanism of action of ketanserin and some ketanserin analogues in the spontaneously hypertensive rat

1 reference

12 December 2020

Acute blood-pressure-lowering effect of ketanserin

1 reference

12 December 2020

Pharmacokinetic parameter estimates from several least squares procedures: superiority of extended least squares.

1 reference

12 December 2020

Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension

1 reference

12 December 2020

Pharmacokinetic approach to equilibrium between ketanserin and ketanserin-ol

1 reference

12 December 2020

Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.

1 reference

12 December 2020

Effect of ketanserin on the hyperreactivity of platelets to 5-hydroxytryptamine in patients with cardiovascular diseases

1 reference

12 December 2020

Bioavailability and pharmacokinetics of ketanserin in elderly subjects

1 reference

12 December 2020

Pharmacology of potent and selective S2-serotonergic antagonists

1 reference

12 December 2020

Ketanserin in essential hypertension: effects during rest and exercise

1 reference

12 December 2020

Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist

1 reference

12 December 2020

Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension

1 reference

12 December 2020

Cardiovascular pharmacology of ketanserin

1 reference

12 December 2020

5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00607573

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3595699%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 September 2019

0 references

1 reference